NGL Fine-Chem Ltd

NGLFINE

Company Profile

  • Business description

    NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.

  • Contact

    301, E Square, Subhash Road
    Vile Parle (East)
    MumbaiMH400057
    IND

    T: +91 2240842222

    https://www.nglfinechem.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2026

    Employees

    523

Stocks News & Analysis

stocks

ASX listed gold miner under pressure due to lower production

Shares have dropped nearly 20% since lowering 2026 volume guidance.
stocks

3 ASX opportunities after earnings season

Uncovering key opportunities following February’s results.
stocks

Oracle earnings: Solid execution secures revenue target and mitigates investor concerns

We raise our fair value estimate for Oracle stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,819.409.30-0.11%
CAC 407,974.4938.520.49%
DAX 4023,730.92166.910.71%
Dow JONES (US)47,093.49147.080.31%
FTSE 10010,403.6085.910.83%
HKSE25,868.5434.520.13%
NASDAQ22,490.88116.710.52%
Nikkei 22553,700.3950.76-0.09%
NZX 50 Index13,182.2317.650.13%
S&P 5006,726.5227.140.41%
S&P/ASX 2008,614.304.40-0.05%
SSE Composite Index4,049.9134.88-0.85%

Market Movers